TNF Pharmaceuticals
  • Contact TNF
  • About Us
    • Team
  • Pipeline
    • MYMD-1®
    • Supera-CBD
  • Research
    • Clinical Trials
  • Investors
  • News
    • TNF News
    • Press Releases
    • Thought leadership
    • Perspectives
  • Subscribe
  • Contact TNF

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Jul 27, 2021 9:15am EDT

MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shows Commonality in Comparative Study with FDA-Approved Anti-Inflammatory and Anti-Autoimmune Drugs Used for Arthritis, Colitis and Dermatitis

Jul 07, 2021 9:00am EDT

MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1

Jun 07, 2021 10:02am EDT

MyMD Pharmaceuticals Set to Join Russell Microcap® Index

May 17, 2021 9:00am EDT

MyMD Pharmaceuticals Appoints David Rini, Professor at the Johns Hopkins School of Medicine, to Scientific Advisory Board

May 12, 2021 9:00am EDT

MyMD Pharmaceuticals Schedules Business Update Conference Call

Apr 28, 2021 10:13am EDT

Johns Hopkins Medicine Researchers to Present Data on MyMD Pharmaceuticals’ Supera-CBD at the 3rd Annual Neuroimmunology Drug Development Summit

Apr 22, 2021 9:20am EDT

MyMD Pharmaceuticals Announces Issuance of Allowance from United States Patent and Trademark Office for Synthetic Cannabinoid Compounds

Apr 19, 2021 9:00am EDT

MyMD Pharmaceuticals Begins Trading on Nasdaq

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

Connect with TNF Pharmaceuticals

Subscribe to stay up-to-date on new developments.

Contact Us

TNF Pharmaceuticals

© 2025 TNF Pharmaceuticals™. All Right Reserved

  • Privacy Policy
  • Terms & Conditions

This site is not intended to provide medical advice or to suggest that any product mentioned is safe or efficacious for any disease or condition.

News & Resources

View a collection of articles, thought leadership content and industry news.

Subscribe to receive TNF announcements
  • This field is for validation purposes and should be left unchanged.